Brief: Recro Reports Fourth Quarter And Year End 2020 Results
26/02/2021 12:12
Feb 26 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL
RESULTS
* Q4 REVENUE $9.9 MILLION VERSUS $17.6 MILLION
* Q4 LOSS PER SHARE $0.48 INCLUDING ITEMS
* SEES Q1 REVENUE UP ABOUT 65 TO 70 PERCENT
Source text for Eikon: ID:nGNX9pYVsR
Further company coverage: REPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview